Amoéba Achieves Milestone in Fundraising Efforts

Amoéba, a leading greentech company specializing in microbiological solutions, has completed the first phase of its fundraising campaign, successfully raising €7.9 million through a private placement with qualified investors. This marks a crucial step towards the company's goal of financial self-sufficiency. The capital increase was achieved via an accelerated bookbuilding process, with new shares issued at €0.416 each.

Overall, the two-part capital raising effort aims to generate over €18 million, covering Amoéba's financing needs for the next year. The monetization of its WillaTM cosmetics asset, anticipated in 2027, is expected to further bolster financial resources. Amoéba targets achieving a revenue of €40 million by 2030 with a current operating margin exceeding 10%.

Further fundraising efforts include a capital increase open to all investors, with preferential subscription rights offered from October 8 to October 23, 2026. This phase hopes to raise an additional €10 million.